Following the recent district court decision to remand to the Department of Health and Human Services the question of how to repay 340B hospitals for funds unlawfully withheld for five years, AHA today asked to meet with the responsible HHS team to discuss its forthcoming remedial proposal. The letter also offered five guiding principles in the hope of expediting this administrative process and avoiding further legal challenges. 

Specifically, the letter calls for HHS to: 

鈥    Repay each 340B hospital the full amount that was unlawfully withheld between January 2018 and September 2022;
鈥    Repay each 340B hospital promptly;
鈥    Not impose a prospective remedy; 
鈥    Pay hospitals interest on its underpayments until they are fully repaid; and 
鈥    Not recoup funds from the hospital field to achieve budget neutrality. 

鈥淎s the AHA has stated before, we are willing to work with HHS to assure a fair and equitable resolution of these issues, which have already taken far too long to resolve, at great cost to the entire hospital field,鈥 the AHA letter states. 鈥淲orking together, HHS and the AHA can develop a fair and administrable remedy that avoids further legal or administrative delay.鈥

View the AHA letter for more details on each of these principles. 

Related News Articles

Chairperson's File
Public
Advocacy is such an important part of what we do as hospitals and health systems 鈥 and what the AHA does on behalf of our field 鈥 to help ensure that we get鈥
Headline
The AHA June 4 filed an amicus brief in the U.S. District Court for the Middle District of Tennessee in defense of the state鈥檚 340B contract pharmacy law鈥
Headline
A U.S. district court judge for the District of Columbia May 15 ruled the Department of Health and Human Services must preapprove the use of 340B 鈥渞ebate鈥
Headline
The AHA May 14 filed an amicus brief in the U.S. District Court for the District of South Dakota in defense of the state鈥檚 340B contract pharmacy law鈥
Headline
The AHA May 9 urged the Department of Health and Human Services to deny drug companies鈥 requests to approve their unlawful 340B rebate models. 鈥淭he 340B鈥
Headline
The AHA May 8 filed an amicus brief in the U.S. District Court for the District of Nebraska in defense of the state鈥檚 340B contract pharmacy law prohibiting鈥